Search

Your search keyword '"Rajkovic-Hooley, Olivera"' showing total 14 results
Start Over Author "Rajkovic-Hooley, Olivera"
14 results on '"Rajkovic-Hooley, Olivera"'

3. Patients with radioiodine-refractory differentiated thyroid cancer (RAI-R DTC) with BRAF V600E and/or K601E mutation status: A real-world view of effectiveness of lenvatinib monotherapy.

Author

Worden, Francis P., primary, Wirth, Lori J., additional, Reynolds, Neil, additional, Cooper, Charley, additional, Rajkovic-Hooley, Olivera, additional, Milligan, Gary, additional, Pham, Phananh, additional, Saal, Hakim, additional, and Brose, Marcia S., additional

Published
2024
Full Text
View/download PDF

6. Real world utilisation of doravirine among people living with human immunodeficiency virus in England (DRIVE-REAL)

Author

O’Halloran, Charlotte, primary, Gilleece, Yvonne, additional, Leung, Suki, additional, Canuto, Veronica, additional, McAlpine, Connor, additional, Ross, Sophie, additional, Norcross, Claire, additional, Gaffney, Stuart, additional, Siani, Nipur, additional, Hickey, William, additional, Moore, Adam, additional, Rajkovic-Hooley, Olivera, additional, and Milinkovic, Ana, additional

Published
2023
Full Text
View/download PDF

7. Real world utilisation of doravirine among people living with human immunodeficiency virus in England (DRIVE-REAL)

Author

O’Halloran, Charlotte, Gilleece, Yvonne, Leung, Suki, Canuto, Veronica, McAlpine, Connor, Ross, Sophie, Norcross, Claire, Gaffney, Stuart, Siani, Nipur, Hickey, William, Moore, Adam, Rajkovic-Hooley, Olivera, and Milinkovic, Ana

Abstract

Background Doravirine is a non-nucleoside reverse transcriptase inhibitor recommended for the treatment of virologically suppressed and treatment naïve people living with HIV. The DRIVE-REAL study aimed to describe the characteristics, treatment patterns, and virological outcomes of doravirine users in a real-world cohort in the UK.Methods A retrospective, observational, multi-centre chart review was conducted for 300 adults living with HIV initiating doravirine-containing antiretroviral therapy.Results At baseline 83% of individuals were male, 45% aged ≥50 years, 65% white ethnicity. Median time since HIV diagnosis was 12 years. 96% were antiretroviral therapy-experienced, 87% had a HIV viral load <50 copies/ml, and 15% had resistance to at least one antiretroviral drug. 66% had comorbidities, most commonly depression (26%), and 70% were taking at least one co-medication. At six months, 94% (n= 283/300) were still receiving doravirine. Viral load data were available for n= 266/300 individuals and 95% (n= 253/266) had viral load <50 copies/ml.Conclusions Individuals initiating doravirine in this cohort are predominantly treatment-experienced white middle-aged males, with a high frequency of comorbidities and co-medication. The majority of individuals at 6 months remained on doravirine and maintained or achieved HIV viral suppression. This study provides epidemiologic characteristics that can inform clinical care and subsequent hypothesis-testing studies.

Published
2024
Full Text
View/download PDF

8. Burden of disease, treatment utilization, and the impact on education and employment in patients with sickle cell disease: A comparative analysis of high‐ and low‐ to middle‐income countries for the international Sickle Cell World Assessment Survey ( SWAY )

Author

Osunkwo, Ifeyinwa, primary, James, John, additional, El‐Rassi, Fuad, additional, Nero, Alecia, additional, Minniti, Caterina P., additional, Trimnell, Cassandra, additional, Paulose, Jincy, additional, Ramscar, Nicholas, additional, Bailey, Tom, additional, Rajkovic‐Hooley, Olivera, additional, and Andemariam, Biree, additional

Published
2022
Full Text
View/download PDF

9. Experiences of Sickle Cell Disease (SCD) Reported By Healthcare Professionals (HCPs) across Different Regions: International Sickle Cell World Assessment Survey (SWAY)

Author

Osunkwo, Ifeyinwa, primary, Andemariam, Biree, additional, Minniti, Caterina P, additional, El Rassi, Fuad, additional, Nur, Erfan, additional, Nero, Alecia C, additional, Colombatti, Raffaella, additional, de Montalembert, Mariane, additional, Abboud, Miguel R, additional, Arlet, Jean-Benoît, additional, Jain, Suman, additional, Jastaniah, Wasil, additional, Pita, Marimilia, additional, Francis-Gibson, Beverley, additional, Trimnell, Cassandra, additional, DeBonnett, Laurie, additional, Bailey, Tom, additional, Rajkovic-Hooley, Olivera, additional, Inusa, Baba PD, additional, and James, John, additional

Published
2021
Full Text
View/download PDF

11. An Age Analysis of the International Sickle Cell World Assessment Survey (SWAY), Focusing on Symptoms, Treatment Goals and the Impact of SCD on Patients' Daily Lives

Author

Colombatti, Raffaella, James, John, Andemariam, Biree, Inusa, Baba PD, El Rassi, Fuad A, Francis-Gibson, Beverley, Nero, Alecia C, Minniti, Caterina P, Trimnell, Cassandra, Abboud, Miguel R, Arlet, Jean-Benoît, de Montalembert, Mariane, Jain, Suman, Jastaniah, Wasil, Nur, Erfan, Pita, Marimilia, Ramscar, Nicholas, Bailey, Tom, Rajkovic-Hooley, Olivera, and Osunkwo, Ifeyinwa

Published
2020
Full Text
View/download PDF

12. Impact of sickle cell disease on patientsʼ daily lives, symptoms reported, and disease management strategies: Results from the international Sickle Cell World Assessment Survey ( SWAY )

Author

Osunkwo, Ifeyinwa, primary, Andemariam, Biree, additional, Minniti, Caterina P., additional, Inusa, Baba P. D., additional, El Rassi, Fuad, additional, Francis‐Gibson, Beverley, additional, Nero, Alecia, additional, Trimnell, Cassandra, additional, Abboud, Miguel R., additional, Arlet, Jean‐Benoît, additional, Colombatti, Raffaella, additional, Montalembert, Mariane, additional, Jain, Suman, additional, Jastaniah, Wasil, additional, Nur, Erfan, additional, Pita, Marimilia, additional, DeBonnett, Laurie, additional, Ramscar, Nicholas, additional, Bailey, Tom, additional, Rajkovic‐Hooley, Olivera, additional, and James, John, additional

Published
2021
Full Text
View/download PDF

13. A retrospective chart review study to quantify the monthly medical resource use and costs of treating patients with treatment resistant depression in the United Kingdom

Author

Denee, Tom, primary, Ming, Timothy, additional, Waller, John, additional, Bailey, Tom, additional, Rajkovic-Hooley, Olivera, additional, Middleton-Dalby, Chloe, additional, Le, Hoa H., additional, Zhang, Qiaoyi, additional, McCrone, Paul, additional, and Taylor, David, additional

Published
2021
Full Text
View/download PDF

14. Global Treatment Satisfaction Levels and Treatment Patterns from the International Sickle Cell World Assessment Survey (SWAY): Hydroxyurea (HU) Versus No HU

Author

El Rassi, Fuad A, primary, James, John, additional, Andemariam, Biree, additional, Inusa, Baba PD, additional, Francis-Gibson, Beverley, additional, Nero, Alecia C, additional, Minniti, Caterina P, additional, Trimnell, Cassandra, additional, Abboud, Miguel R, additional, Arlet, Jean-Benoît, additional, Colombatti, Raffaella, additional, de Montalembert, Mariane, additional, Jain, Suman, additional, Jastaniah, Wasil, additional, Nur, Erfan, additional, Pita, Marimilia, additional, Ramscar, Nicholas, additional, Bailey, Tom, additional, Rajkovic-Hooley, Olivera, additional, and Osunkwo, Ifeyinwa, additional

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results